Treatment of dystonia (Q80304443)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Treatment of dystonia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Joseph Jankovic

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

864-872

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987733%20AND%20SRC:MED&resulttype=core&format=json

Status dystonicus: the syndrome and its management

30 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Treatment outcomes in cervical dystonia: a clinimetric study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Efficacy of pharmacological treatment of dystonia: evidence-based review including meta-analysis of the effect of botulinum toxin and other cure options

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Pallidotomy for generalized dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Rating scales for dystonia: a multicenter assessment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Capturing the true burden of dystonia on patients: the Cervical Dystonia Impact Profile (CDIP-58).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Dystonia in Wilson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

What are the determinants of quality of life in people with cervical dystonia?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Hand orthosis as a writing aid in writer's cramp

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Constraint-induced movement therapy for focal hand dystonia in musicians.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Limb immobilization for the treatment of focal occupational dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Can peripheral trauma induce dystonia and other movement disorders? Yes!

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Constraint-induced movement therapy to enhance recovery after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Repetitive task practice: a critical review of constraint-induced movement therapy in stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Sensory training for patients with focal hand dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Sensory training as treatment for focal hand dystonia: A 1‐year follow‐up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Effect of sensory discrimination training on structure and function in patients with focal hand dystonia: a case series

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Low-frequency repetitive transcranial magnetic stimulation of the motor cortex in writer's cramp

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Effect of prolonged neck muscle vibration on lateral head tilt in severe spasmodic torticollis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

TENS for the treatment of writer's cramp dystonia: A randomized, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Dopa-responsive dystonia: mutation analysis of GCH1 and analysis of therapeutic doses of L-dopa. German Dystonia Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Familial dopa-responsive cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Heterozygous mutation in 5'-untranslated region of sepiapterin reductase gene (SPR) in a patient with dopa-responsive dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

An open trial of clozapine for dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Long-term effects of tetrabenazine in hyperkinetic movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Tetrabenazine in the treatment of hyperkinetic movement disorders

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Age-dependent effects of trihexyphenidyl in extrapyramidal cerebral palsy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Intrathecal baclofen for intractable axial dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Intrathecal baclofen for dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Intrathecal baclofen for stiff-person syndrome: life-threatening intermittent catheter leakage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Morphine in tardive and idiopathic dystonia (short communication).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

gamma-hydroxybutyric acid for alcohol-sensitive myoclonus with dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Paroxysmal kinesigenic dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Muscle afferent block by intramuscular injection of lidocaine for the treatment of writer's cramp.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Muscle afferent block for the treatment of oromandibular dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Mexiletine in the treatment of spasmodic torticollis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Mexiletine in the treatment of torticollis and generalized dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Is dystonia a sensory disorder?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Clinical doxorubicin chemomyectomy. An experimental treatment for benign essential blepharospasm and hemifacial spasm

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Utilization and perceived effectiveness of complementary and alternative medicine in patients with dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Botulinum toxin in clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Treating severe bruxism with botulinum toxin

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Trismus after stroke/TBI: botulinum toxin benefit and use pre-PEG placement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Botulinum toxin injections in the treatment of musician's dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

SV2 is the protein receptor for botulinum neurotoxin A.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

The synaptic vesicle protein 2C mediates the uptake of botulinum neurotoxin A into phrenic nerves

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

A new botulinum toxin type A free of complexing proteins for treatment of cervical dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Autonomic function after botulinum toxin type A or B: a double-blind, randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Safety of botulinum toxin type A: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Evidence-based review of patient-reported outcomes with botulinum toxin type A.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Long-term botulinum toxin efficacy, safety, and immunogenicity.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Electrical stimulation of the globus pallidus internus in patients with primary generalized dystonia: long-term results.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Globus pallidus deep brain stimulation in dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Primary dystonia is more responsive than secondary dystonia to pallidal interventions: outcome after pallidotomy or pallidal deep brain stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Suicide after deep brain stimulation of the internal globus pallidus for dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Pallidal stimulation in dystonia: effects on cognition, mood, and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Bilateral deep-brain stimulation of the globus pallidus in primary generalized dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Pallidal deep brain stimulation in patients with cervical dystonia and severe cervical dyskinesias with cervical myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Treatment of severe tardive dystonia with pallidal deep brain stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Symptomatic and functional outcome of surgical treatment of cervical dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Outcome of selective ramisectomy for botulinum toxin resistant torticollis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Follow-up of patients with essential blepharospasm who underwent eyelid protractor myectomy at the Mayo Clinic from 1980 through 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Intermediate results of 306 recurrent laryngeal nerve sections for spastic dysphonia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Toward therapy for DYT1 dystonia: allele-specific silencing of mutant TorsinA

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

Silencing primary dystonia: lentiviral-mediated RNA interference therapy for DYT1 dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970574-9

7 January 2021

10.1016/S1474-4422(06)70574-9

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16987733%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1 reference